Upanovimab
Upanovimab (SCTA01) is a monoclonal antibody that targets the SARS-CoV-2 S protein[1].
Product Specifications
CAS Number
[2500633-46-3]
Product Name Alternative
SCTA01
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/upanovimab.html
Purity
95.627
Solubility
10 mM in DMSO
Smiles
[Upanovimab]
Molecular Weight
(145.633 kDa)
Precautions
H302, H315, H319, H335
References & Citations
[1]Daniele Focosi, et al. Monoclonal antibody therapies against SARS-CoV-2. Lancet Infect Dis. 2022 Nov;22 (11) :e311-e326.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items